Skip to content
Pass Duke Elder
Textbook / Chapter 14 / Ocular pathology, genetics and systemic associations

Immunology, HLA associations and hypersensitivity

The eye cannot afford ordinary inflammation, so it has its own rules for restraining the immune system, and when those rules fail the result is uveitis, graft rejection or sympathetic ophthalmia. This lesson explains immune privilege, the four types of hypersensitivity with an eye example of each, the HLA associations that are asked every year, and how a corneal graft is rejected.

10 minute read3 linked questions

Immune privilege

Inflammation defends tissue by damaging it a little: vessels leak, cells are killed, scars form. Skin can absorb that cost. The cornea, lens and retina cannot, because their function depends on transparency and exact structure, and the retina cannot replace lost neurones. The eye therefore tolerates antigens that would provoke a vigorous response elsewhere. This is immune privilege: the ability of certain sites to accept foreign antigen without mounting a destructive inflammatory response. The other privileged sites are the brain, the testis and the pregnant uterus. The idea is associated with Peter Medawar, who studied the survival of grafts in privileged sites.

Privilege was once thought to be passive, a matter of antigens being hidden. It is now understood as several active mechanisms working together:

  • Barriers and drainage. The blood-ocular barriers keep cells and proteins out, and the interior of the eye has little lymphatic drainage, so antigen does not reach lymph nodes by the usual route.
  • Low expression of MHC molecules. Ocular cells display few of the molecules that present antigen to T cells, so they are poor targets.
  • An immunosuppressive fluid. Aqueous humour contains transforming growth factor beta and other factors that inhibit T cells and complement.
  • Fas ligand. Cells lining the eye carry Fas ligand on their surface. An activated T cell that enters carries the Fas receptor, and the meeting triggers the T cell to die by apoptosis.
  • Anterior chamber associated immune deviation (ACAID). Antigen placed in the anterior chamber does not simply go unnoticed. It induces a body-wide suppression of the damaging, delayed-type response to that particular antigen.

The cornea adds its own reasons: it has no blood vessels and no lymphatics, so immune cells cannot easily arrive and antigen cannot easily leave. This is why corneal grafts succeed without tissue matching far more often than grafts of other organs.

Privilege has a price. Because some ocular antigens are never shown to the developing immune system, the body does not learn to tolerate them. If a penetrating injury releases them to the lymph nodes, T cells can be sensitised and then attack both eyes. This is sympathetic ophthalmia, described in the uveitis chapter.

The four types of hypersensitivity

Hypersensitivity is an immune response that damages the host. The Gell and Coombs classification divides it into four types by mechanism. Types I to III are caused by antibody and type IV by T cells. Speed is a useful guide: type I acts within minutes, types II and III over hours to days, and type IV peaks at two to three days.

TypeMechanismEye examples
I: immediateAllergen cross-links IgE on mast cells, which release histamineSeasonal and perennial allergic conjunctivitis; part of vernal keratoconjunctivitis
II: antibody against cell or matrixIgG or IgM binds a fixed antigen on a cell or basement membrane and activates complementOcular cicatricial pemphigoid; myasthenia gravis; Graves disease
III: immune complexSoluble antigen-antibody complexes deposit in tissue and vessel walls, fix complement and attract neutrophilsStaphylococcal marginal keratitis; the vasculitis of systemic lupus erythematosus
IV: delayed, cell mediatedSensitised T cells release cytokines and recruit macrophagesPhlyctenulosis; contact dermatitis of the lids; corneal graft rejection; granulomatous disease
Hypersensitivity types with eye examples

Type I. On first exposure the patient makes IgE against pollen or house dust mite, and the IgE coats mast cells in the conjunctiva. On the next exposure the allergen bridges neighbouring IgE molecules and the mast cell empties its granules. Histamine causes the itch, redness and swelling within minutes. This explains why antihistamines and mast cell stabilisers work. Vernal keratoconjunctivitis is not purely type I: T helper 2 cells and eosinophils drive a type IV component, which is why it produces giant papillae and can ulcerate the cornea.

Type II. The antibody is directed at something fixed in place. In ocular cicatricial pemphigoid autoantibodies bind the basement membrane of the conjunctival epithelium, and immunofluorescence of a biopsy shows a line of staining along it. The resulting inflammation scars the conjunctiva, shortening the fornices and tying lid to globe. Type II antibodies can also act on receptors without killing the cell: they block the acetylcholine receptor in myasthenia gravis and stimulate the thyroid stimulating hormone receptor in Graves disease.

Type III. Here the antigen is soluble, and the damage occurs wherever the complexes settle. In marginal keratitis antibody meets staphylococcal antigen diffusing from the lid margin into the peripheral cornea. Complexes deposit in the stroma, complement is activated and neutrophils arrive, forming a sterile infiltrate separated from the limbus by a clear interval. There is no infection of the cornea itself, so treatment is of the lids, with a short course of topical steroid.

Type IV. No antibody is involved. Memory T cells recognise antigen presented to them and call in macrophages. The tuberculin skin test is the model. A phlyctenule is the ocular version: a small inflamed nodule at the limbus caused by a T cell response to staphylococcal antigen, or historically to tuberculous antigen. Granulomas, and so the granulomatous uveitis of sarcoidosis and tuberculosis, are type IV reactions that have become chronic.

HLA and the MHC

T cells cannot see free antigen. They recognise fragments of it held in a groove on a cell surface molecule. These molecules are encoded by the major histocompatibility complex (MHC), which in humans is called the human leukocyte antigen (HLA) system and lies on chromosome 6.

  • Class I molecules are HLA-A, HLA-B and HLA-C. They display peptides made inside the cell, such as viral proteins, to CD8 cytotoxic T cells, which kill the cell.
  • Class II molecules are HLA-DP, HLA-DQ and HLA-DR. They are found mainly on antigen presenting cells and display material taken up from outside the cell to CD4 helper T cells.

HLA genes vary greatly between people, and each variant holds a slightly different range of peptides. A variant that happens to present a self peptide well may predispose to an autoimmune disease, which is the likely basis of the associations below. HLA difference between donor and recipient is also the main cause of transplant rejection.

HLA associations to learn

HLA typeClassEye diseaseNote
HLA-B27IAcute anterior uveitis, with ankylosing spondylitis, reactive arthritis and inflammatory bowel diseaseAbout half of acute anterior uveitis is B27 associated
HLA-A29IBirdshot chorioretinopathyPresent in 80 to 98% of patients; the strongest known link of a disease with a class I type
HLA-B51IBehçet diseaseA risk factor, not a diagnostic test
HLA-DR4IIVogt-Koyanagi-Harada disease; ocular cicatricial pemphigoidThe pemphigoid link is also with HLA-DQB1*0301
HLA-DR15 (a split of DR2)IIIntermediate uveitis (pars planitis); multiple sclerosis and optic neuritisExplains why the two conditions travel together
HLA types and eye disease

An HLA type raises risk. It does not make a diagnosis. HLA-B27 is carried by about 8 to 10% of white Europeans, almost all of whom will never have uveitis, so a positive result in a patient with an atypical picture proves nothing. The test earns its place when the clinical picture already fits: a positive HLA-B27 in a young adult with recurrent unilateral acute anterior uveitis prompts a search for inflammatory back pain. HLA-A29 is carried by about 7% of the general population, and birdshot is rare, so the same caution applies even to the strongest association.

Autoimmunity

Autoimmunity is an immune response against the body's own tissue. Tolerance to self normally depends on deleting or silencing self-reactive lymphocytes. It can fail in several ways that have ocular examples. An antigen that was hidden may be released, as in sympathetic ophthalmia. A microbe may carry an antigen resembling a self antigen, so that the response to infection cross-reacts with self, an idea called molecular mimicry. And an inherited HLA type may present a self peptide unusually well.

Autoimmune disease reaches the eye by each of the hypersensitivity routes. Autoantibody against a receptor causes myasthenia gravis and Graves disease. In thyroid eye disease the autoimmune process activates orbital fibroblasts, which lay down water-binding glycosaminoglycans and expand the muscles and fat. Immune-mediated vasculitis underlies the scleritis and peripheral corneal melting of rheumatoid arthritis and related diseases. T cells directed at melanocytes are thought to cause Vogt-Koyanagi-Harada disease. These diseases are taught in their own chapters.

Corneal graft rejection

A corneal graft is among the most successful of all transplants. In a low-risk first full-thickness graft, survival is up to 95% at five years with topical steroid alone. Privilege is lost when the recipient bed is abnormal. The main risk factors are blood vessels in more than two quadrants of the host cornea, a previous rejected graft, active inflammation, a young recipient and a large graft that sits close to the limbus. In high-risk grafts failure can exceed 35% at three years.

Rejection is a T cell response to donor antigens and can be directed at any cellular layer of the graft.

  • Epithelial rejection: a raised line that moves across the donor epithelium. It responds well to steroid but can come before endothelial rejection.
  • Subepithelial rejection: small infiltrates under the epithelium, confined to the graft.
  • Endothelial rejection: the commonest and most serious form, about half of all episodes. Keratic precipitates appear on the graft, sometimes arranged in a line, the Khodadoust line, which advances across the endothelium leaving swollen cornea behind it.

Endothelial rejection matters because human endothelial cells do not divide. Every cell killed is lost for good, and once too few remain the graft swells and fails. The patient notices a red, light-sensitive eye with falling vision, most often in the first year or two, though rejection can occur decades later. Treatment is urgent, intensive topical steroid, with systemic steroid in severe episodes. Grafts that replace only one layer carry less foreign tissue and reject less: the reported rate for a Descemet membrane endothelial graft is about 2%.

Summary

  • Immune privilege is the eye's active restraint of inflammation, through barriers, low MHC expression, immunosuppressive aqueous, Fas ligand and ACAID.
  • The cornea is privileged because it has no blood vessels and no lymphatics.
  • Type I hypersensitivity is IgE on mast cells (allergic conjunctivitis); type II is antibody against a fixed antigen (ocular cicatricial pemphigoid).
  • Type III is immune complex deposition (marginal keratitis); type IV is T cell mediated (phlyctenulosis, graft rejection, granulomas).
  • HLA genes lie on chromosome 6; class I (A, B, C) present to CD8 T cells and class II (DP, DQ, DR) to CD4 T cells.
  • HLA-B27 goes with acute anterior uveitis, HLA-A29 with birdshot, HLA-B51 with Behçet disease, HLA-DR4 with Vogt-Koyanagi-Harada disease and HLA-DR15 with intermediate uveitis and multiple sclerosis.
  • An HLA type is a risk factor, not a diagnostic test: HLA-B27 is carried by about 8 to 10% of white Europeans.
  • Corneal vascularisation in more than two quadrants and a previous rejection are the main risk factors for graft rejection.
  • Endothelial rejection, with a Khodadoust line, is the commonest and most serious form and needs urgent intensive topical steroid.

Check yourself

Quick recall on this lesson. These are easier than the question bank.

1. Which type of hypersensitivity underlies staphylococcal marginal keratitis?
2. Which HLA type is associated with birdshot chorioretinopathy?
3. Which feature of a host cornea most increases the risk of graft rejection?
4. HLA class II molecules present antigen to which cells?
Practise 3 questions on this lesson

Written for revision. It is not a source of clinical advice, and guidance changes.